From January 1, 2024 to March 31, 2024, the company has repurchased 8,575,800 shares, representing 1.67% for CNY 70.58 million. With this, the company has completed the repurchase of 8,575,800 shares, representing 1.67% for CNY 70.58 million under the buyback announced on October 29, 2023.
Shanghai Kehua Bio-Engineering Co.,Ltd
Equities
002022
CNE000001KC9
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7.36 CNY | +0.68% | +8.24% | -35.33% |
Apr. 28 | Shanghai Kehua Bio-Engineering Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 15 | Kehua Bio-Engineering Gets Registration Certificates for Two Devices | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-35.33% | 523M | |
-0.60% | 12.63B | |
-9.59% | 7.67B | |
+1.82% | 5.42B | |
+0.02% | 4.57B | |
-51.89% | 3.51B | |
+6.42% | 2.59B | |
-14.59% | 2.05B | |
-8.29% | 1.79B | |
+1.67% | 1.77B |
- Stock Market
- Equities
- 002022 Stock
- News Shanghai Kehua Bio-Engineering Co.,Ltd
- Tranche Update on Shanghai Kehua Bio-Engineering Co.,Ltd's Equity Buyback Plan announced on October 29, 2023.